Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al
=============================================================================================================================================================

* Lena Immisch
* George Papafotiou
* Oliver Popp
* Philipp Mertins
* Thomas Blankenstein
* Gerald Willimsky